Overall, according to nonclinical data, TH signaling is implicated in lung cancer progression, but its effect can be either promoting or inhibitory depending, at least partially, on TH type (T3 or T4), TR type and isoform, TH concentration, and activated molecular pathways. This evidence concerns the gene TH and lung cancer.